about
Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study.Design, characterization, and in vitro evaluation of antifungal polymeric filmsFirst century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.Elucidating the guest-host interactions and complex formation of praziquantel and cyclodextrin derivatives by (13)C and (15)N solid-state NMR spectroscopy.Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.Formulation and in-vitro efficacy of antifungal mucoadhesive polymeric matrices for the delivery of miconazole nitrate.Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole.Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.First solid-state NMR spectroscopy evaluation of complexes of benznidazole with cyclodextrin derivatives.Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.(13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.Report from the 2nd annual RICiFa meeting (International Meeting on Pharmaceutical Sciences 2012).Report from the 1st annual RICiFA meeting (International Meeting on Pharmaceutical Sciences 2010).In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans.Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats.Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound.Influence of water uptake, gel network, and disintegration time on prednisone release from encapsulated solid dispersions.Preparation, characterization and dissolution studies of fast release diclofenac sodium tablets from PVP solid dispersions.Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets.High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection.Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.Development and Evaluation of Buccal Films Based on Chitosan for the Potential Treatment of Oral Candidiasis.Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.Stealth nanocarriers based sterosomes using PEG post-insertion process.Recent Trends in the Development of Chitosan-Based Drug Delivery Systems.In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions—a metabolic approachA Practical Method for the Disposal of Organotin Residues from Reaction MixturesInteraction of Myosin Subfragment 1 with Two Non-Nucleotide ATP AnaloguesChitosan-based nanodelivery systems applied to the development of novel triclabendazole formulationsSolving the Delivery Problems of Triclabendazole Using CyclodextrinsDevelopment and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A reviewNanodelivery of nitazoxanide: impact on the metabolism of Taenia crassiceps cysticerci intracranially inoculated in mice
P50
Q31120627-73FB414B-18E3-4A00-825F-11059A0D4CF7Q36636474-DA6298A1-F195-4EF5-AC18-04423DE302E9Q37967569-CD81517F-2A78-4737-855B-291FC9FEDC09Q38552573-EFC940D3-3291-452C-8719-DF29C0FF2608Q38880668-B1ABFF32-37F5-499E-954B-2E84AE488927Q39463265-8FA8FB3D-CF2E-4E0D-AD2F-5C4D3A5C02E1Q40154144-3D9A5D95-AD50-4DC8-BE6B-07A3B4471892Q40350362-13A560A2-F1B7-43E2-BA0D-E22FAD194231Q40556826-B2936D09-48FD-4CD3-99B6-D20925C41314Q40644159-6CD7DB4A-8415-4429-913F-41F6315C48D7Q40651110-7D51BDF5-56FF-4955-8DFF-7F548FA1A333Q41113704-C0768706-C856-42C7-A01A-48BE8ACBCC61Q42388303-FB8BDF19-E99A-4BE4-AC76-40EB00DB9475Q42796702-2BEFDE78-2AEB-4A5D-AED9-81E9B5B38974Q43116451-5F35CAEA-C5B7-4E54-8295-447619F0D4BBQ44630812-4E8AF8A4-9B61-442D-8A65-7146E49DF5DFQ44786257-8E1F5BF3-5670-49E9-AE55-31DCBCD6A38FQ44938486-EEAD7F7F-884A-40D7-9981-A37E3253E721Q45923983-AB901639-B539-45B0-927D-5DF14DF7E62AQ45934149-DC84A991-344C-45FB-8467-C7D1C0BB9784Q45934994-3939B5E3-32F9-4FCA-9F35-CD768E63E506Q45982102-8A94078B-3BC4-48DC-A08C-6BDF017F7F1FQ46306728-640DF4A1-4396-4799-AA88-5C651E18AB51Q46429808-BC216D5A-BB0A-4990-9891-10AD6663C7C1Q48364827-53FC7E2B-D936-4A6E-917E-F60FF679F2C4Q48827008-AA94CDC4-27B0-4B2F-AA1D-B16038474F29Q52810648-98AE5BD0-06AC-4D6D-95C0-EF054AE7289DQ58854071-819D92F3-0127-45F6-B283-CB9FE4F4419BQ58854079-AA5E0A0E-7DAE-4CFB-BDD9-61FDEA4454FBQ58854081-2966DE80-5B7D-44AE-A746-A4169118AA10Q60303099-49ECAAC6-3B12-44A8-A983-71733A2CFB25Q88913480-2BDC6421-C289-481E-96E5-F1F052B21C6DQ91400835-553C3279-EECC-4B38-A025-F962CAB786F7Q91830548-F1700D07-FEF8-46B8-AC93-0D8F285CA8E1Q96121423-B95A9C13-5BC4-4A09-9862-84A7DCA35212
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudio J. Salomon
@ast
Claudio J. Salomon
@en
Claudio J. Salomon
@es
Claudio J. Salomon
@nl
Claudio J. Salomon
@sl
type
label
Claudio J. Salomon
@ast
Claudio J. Salomon
@en
Claudio J. Salomon
@es
Claudio J. Salomon
@nl
Claudio J. Salomon
@sl
prefLabel
Claudio J. Salomon
@ast
Claudio J. Salomon
@en
Claudio J. Salomon
@es
Claudio J. Salomon
@nl
Claudio J. Salomon
@sl
P106
P1153
36949563300
P21
P31
P496
0000-0003-1599-790X